Brynn Carrigan, a 41-year-old health official from Bakersfield, California, never imagined that what began as persistent headaches in April 2024 would spiral into a life-altering health crisis. Once an active mother of two and a marathon trainee, Carrigan suddenly found herself bedridden, unable to tolerate even the dimmest light. Her vomiting worsened the pain, and she spent most days hidden under blankets in complete darkness. Simple things like the glow of a microwave clock became unbearable as her condition deteriorated.

Doctors were initially perplexed, unable to pinpoint a diagnosis despite multiple hospital visits. It wasn’t until her third trip to the emergency room that a doctor asked an important question that would change the course of her treatment: had she experienced any respiratory symptoms prior to the headaches? The answer was yes. About a month earlier, she had what seemed like a typical cold, followed by a stubborn cough and an unusual rash on her thighs. Both symptoms resolved on their own, so she never considered them significant. However, these details proved crucial. A spinal fluid biopsy finally confirmed that Carrigan was suffering from coccidioidal meningitis, a rare but severe complication of a fungal disease known as Valley fever.

Carrigan’s experience is not an isolated case but part of a growing health concern across the western United States, especially in California. Valley fever, medically known as coccidioidomycosis, is caused by inhaling microscopic spores of the fungus coccidioides, which thrives in dry, dusty environments. Once considered mostly confined to the southwestern United States, the fungus is now being found farther east due to climate changes that are drying out soils and expanding suitable habitats for the spores. The condition is typically contracted by inhaling airborne spores, which can happen simply by being outdoors on a windy day in an endemic area.

In the past, Arizona led the nation in Valley fever cases, but California is quickly catching up. Between 2000 and 2016, California averaged 1,500 to 5,500 cases per year. That number dramatically increased between 2017 and 2023, with annual reports climbing to between 7,700 and 9,000 cases. Now, preliminary data for 2024 shows an even more alarming surge, with over 12,600 cases already reported. That’s approximately 3,000 more than the previous record set in 2023, marking the highest tally the state has ever experienced.

Early reports for the current year suggest California is again on track to set a new record. More than 3,000 cases have been confirmed statewide, significantly exceeding the figures for the same period in 2023. Health experts are closely monitoring this increase, especially as the infection continues to appear in counties that were not traditionally considered at high risk. Rising temperatures and shifting rainfall patterns are creating ideal conditions for the fungus to thrive and spread.

Carrigan’s story highlights the dangers of delayed diagnosis and the devastating impact Valley fever can have if not treated early. Meningitis resulting from this infection is rare but extremely serious, requiring long-term antifungal treatment and, in some cases, ongoing medical monitoring for years. The fact that the disease can mimic common illnesses like the cold or flu adds to the challenge of early detection. Many patients, like Carrigan, do not initially connect their mild respiratory symptoms to a fungal infection that could invade their central nervous system weeks later.

Health authorities in California are urging residents and healthcare providers to be more vigilant. Increased public awareness about Valley fever is critical, especially as more cases emerge in areas previously thought to be unaffected. People working or spending time in dusty outdoor environments should take precautions, including wearing masks or staying indoors during dust storms. Prompt attention to lingering respiratory symptoms, skin rashes, or unexplained fatigue may also help identify potential infections before complications arise.

Carrigan, now receiving ongoing treatment, hopes her story encourages others to advocate for their health and push for answers when something doesn’t feel right. She never expected that a fungal infection from the soil could cause her such suffering or that her experience would reflect a broader public health trend. But with California facing unprecedented numbers of Valley fever cases, her ordeal may serve as a warning about the silent expansion of this dangerous disease.